These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30214307)

  • 1. Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of
    Li X; Hong X; Gao X; Gu X; Xiong W; Zhao J; Yu H; Cui M; Xie M; Bai Y; Sun S
    Cancer Manag Res; 2018; 10():3149-3158. PubMed ID: 30214307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation.
    Sun SQ; Gu X; Gao XS; Li Y; Yu H; Xiong W; Yu H; Wang W; Li Y; Teng Y; Zhou D
    Oncotarget; 2016 Jul; 7(30):48050-48058. PubMed ID: 27385003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldo-keto reductase 1C3 is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolism.
    Mantel A; Carpenter-Mendini A; VanBuskirk J; Pentland AP
    Exp Dermatol; 2014 Aug; 23(8):573-8. PubMed ID: 24917395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of aldo-keto reductase 1C3 (AKR1C3)-mediated prostaglandin D2 (PGD2) metabolism in keloids.
    Mantel A; Newsome A; Thekkudan T; Frazier R; Katdare M
    Exp Dermatol; 2016 Jan; 25(1):38-43. PubMed ID: 26308156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldo-keto reductase family member C3 (AKR1C3) promotes hepatocellular carcinoma cell growth by producing prostaglandin F2α.
    Jeng KS; Cheng PY; Lin YH; Liu PC; Tseng PH; Wang YC; Chang CF; Leu CM
    Oncol Res; 2023; 32(1):163-174. PubMed ID: 38188684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldo-keto reductase 1C3 may be a new radioresistance marker in non-small-cell lung cancer.
    Xie L; Yu J; Guo W; Wei L; Liu Y; Wang X; Song X
    Cancer Gene Ther; 2013 Apr; 20(4):260-6. PubMed ID: 23519145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of AKR1C3 increases resistance of cancer cells to ionizing radiation via modulation of oxidative stress.
    Xiong W; Zhao J; Yu H; Li X; Sun S; Li Y; Xia Q; Zhang C; He Q; Gao X; Zhang L; Zhou D
    PLoS One; 2014; 9(11):e111911. PubMed ID: 25419901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer.
    Byrns MC; Duan L; Lee SH; Blair IA; Penning TM
    J Steroid Biochem Mol Biol; 2010 Feb; 118(3):177-87. PubMed ID: 20036328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinoma.
    Miller VL; Lin HK; Murugan P; Fan M; Penning TM; Brame LS; Yang Q; Fung KM
    Int J Clin Exp Pathol; 2012; 5(4):278-89. PubMed ID: 22670171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitors.
    Penning TM; Steckelbroeck S; Bauman DR; Miller MW; Jin Y; Peehl DM; Fung KM; Lin HK
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):182-91. PubMed ID: 16417966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs.
    Desmond JC; Mountford JC; Drayson MT; Walker EA; Hewison M; Ride JP; Luong QT; Hayden RE; Vanin EF; Bunce CM
    Cancer Res; 2003 Jan; 63(2):505-12. PubMed ID: 12543809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of aldo-keto reductase family 1 member C3 (AKR1C3) in neuroendocrine tumors & adenocarcinomas of pancreas, gastrointestinal tract, and lung.
    Chang TS; Lin HK; Rogers KA; Brame LS; Yeh MM; Yang Q; Fung KM
    Int J Clin Exp Pathol; 2013; 6(11):2419-29. PubMed ID: 24228104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AKR1C2 and AKR1C3 mediated prostaglandin D2 metabolism augments the PI3K/Akt proliferative signaling pathway in human prostate cancer cells.
    Wang S; Yang Q; Fung KM; Lin HK
    Mol Cell Endocrinol; 2008 Jul; 289(1-2):60-6. PubMed ID: 18508192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKR1C isoforms represent a novel cellular target for jasmonates alongside their mitochondrial-mediated effects.
    Davies NJ; Hayden RE; Simpson PJ; Birtwistle J; Mayer K; Ride JP; Bunce CM
    Cancer Res; 2009 Jun; 69(11):4769-75. PubMed ID: 19487289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment with peroxisome proliferator-activated receptor (PPAR) gamma ligands and gamma radiation induces apoptosis by PPARγ-independent up-regulation of reactive oxygen species-induced deoxyribonucleic acid damage signals in non-small cell lung cancer cells.
    Han EJ; Im CN; Park SH; Moon EY; Hong SH
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e239-48. PubMed ID: 23332223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldo-Keto Reductase 1C3 Mediates Chemotherapy Resistance in Esophageal Adenocarcinoma via ROS Detoxification.
    Zhou C; Wang Z; Li J; Wu X; Fan N; Li D; Liu F; Plum PS; Hoppe S; Hillmer AM; Quaas A; Gebauer F; Chon SH; Bruns CJ; Zhao Y
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AKR1C3 overexpression mediates methotrexate resistance in choriocarcinoma cells.
    Zhao J; Xiang Y; Xiao C; Guo P; Wang D; Liu Y; Shen Y
    Int J Med Sci; 2014; 11(11):1089-97. PubMed ID: 25170291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiological roles of autophagy and aldo-keto reductases in development of doxorubicin resistance in gastrointestinal cancer cells.
    Matsunaga T; Kawabata S; Yanagihara Y; Kezuka C; Kato M; Morikawa Y; Endo S; Chen H; Iguchi K; Ikari A
    Chem Biol Interact; 2019 Dec; 314():108839. PubMed ID: 31563593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of type 2 3α/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) in tumors of the central nervous system.
    Park AL; Lin HK; Yang Q; Sing CW; Fan M; Mapstone TB; Gross NL; Gumerlock MK; Martin MD; Rabb CH; Fung KM
    Int J Clin Exp Pathol; 2010 Mar; 3(8):743-54. PubMed ID: 21151387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cells.
    Doig CL; Battaglia S; Khanim FL; Bunce CM; Campbell MJ
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):47-55. PubMed ID: 26429394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.